Revised consolidated full-year earnings guidance for the fiscal year ending March 2026 to net sales of 133,000 million yen (up 3.3% from the previous forecast), operating income of 29,600 million yen (up 10.0%), and net income attributable to owners of parent of 20,100 million yen (up 9.2%).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4626","jir_company_name":"Taiyo Holdings Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-02-04","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/02\/4626-20260204-02.pdf","jir_short_summary":"Revised consolidated full-year earnings guidance for the fiscal year ending March 2026 to net sales of 133,000 million yen (up 3.3% from the previous forecast), operating income of 29,600 million yen (up 10.0%), and net income attributable to owners of parent of 20,100 million yen (up 9.2%).","jir_summary":"### Details of Earnings Forecast Revision\nTaiyo Holdings Co., Ltd. has revised its consolidated earnings forecast for the fiscal year ending March 2026. Net sales have been increased by 3.3% from the previous forecast of 128,800 million yen to 133,000 million yen; operating income was raised by 10.0% from 26,900 million yen to 29,600 million yen; ordinary income was revised upward by 9.8% from 26,500 million yen to 29,100 million yen; and net income attributable to owners of parent was increased by 9.2% from 18,400 million yen to 20,100 million yen. Net income per share increased from 165.46 yen to 180.75 yen.\n\n### Reasons for Revision and Dividend Forecast\nThe primary factor for the revision is higher-than-expected demand in the electronics business for semiconductor package substrate materials and rigid substrate materials destined for China. While the fourth quarter forecast remains unchanged, the full-year forecast has been revised to reflect the third quarter results. There are no changes to the earnings forecasts for the Medical & Pharmaceutical business and ICT&S business. The year-end dividend forecast also remains unchanged from the previously announced amount.","jir_financial_highlights":"Net Sales: 133,000 million yen (Up 3.3% from previous forecast)\nOperating Income: 29,600 million yen (Up 10.0% from previous forecast)\nOrdinary Income: 29,100 million yen (Up 9.8% from previous forecast)\nNet Income Attributable to Owners of Parent: 20,100 million yen (Up 9.2% from previous forecast)\nNet Income per Share: 180.75 yen (Increase from previous forecast)","jir_category":"","jir_hashtags":"#TaiyoHoldings, #EarningsGuidanceRevision, #JapaneseStocks","jir_key_figures":"Net Sales: 133,000 million yen (up 3.3% from previous forecast)\nOperating Income: 29,600 million yen (up 10.0% from previous forecast)\nNet Income Attributable to Owners of Parent: 20,100 million yen (up 9.2% from previous forecast)","jir_meta_title":"Taiyo Holdings Revises Full-Year Earnings Guidance for Fiscal 2026 to Net Sales of 133 Billion Yen","jir_meta_description":"Taiyo Holdings has upwardly revised its consolidated full-year earnings guidance for fiscal 2026 to net sales of 133,000 million yen and operating income of 29,600 million yen, driven by increased demand from China in the electronics segment.","jir_og_title":"Taiyo Holdings Upwardly Revises Fiscal 2026 Earnings Guidance","jir_og_description":"Following strong performance in the electronics business, Taiyo Holdings has raised its full-year net sales and profit forecasts for the fiscal year ending March 2026.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Net Sales Trends (million yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2025 Actual\\\",\\\"FY2026 Previous Forecast\\\",\\\"FY2026 Revised Forecast\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[119010,128800,133000],\\\"backgroundColor\\\":\\\"#4e79a7\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Operating Income Trends (million yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2025 Actual\\\",\\\"FY2026 Previous Forecast\\\",\\\"FY2026 Revised Forecast\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[22067,26900,29600],\\\"backgroundColor\\\":\\\"#f28e2b\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"net_profit_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Net Income Attributable to Owners of Parent Trends (million yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2025 Actual\\\",\\\"FY2026 Previous Forecast\\\",\\\"FY2026 Revised Forecast\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Income\\\",\\\"data\\\":[10780,18400,20100],\\\"backgroundColor\\\":\\\"#e15759\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Revenue Comparison (million yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Electronics Business\\\",\\\"Medical & Pharmaceutical Business\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"FY2025 Actual\\\",\\\"data\\\":[81703,31558],\\\"backgroundColor\\\":\\\"#4e79a7\\\"},{\\\"label\\\":\\\"FY2026 Revised Forecast\\\",\\\"data\\\":[91100,35400],\\\"backgroundColor\\\":\\\"#76b7b2\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_operating_profit_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Operating Income Comparison (million yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Electronics Business\\\",\\\"Medical & Pharmaceutical Business\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"FY2025 Actual\\\",\\\"data\\\":[21458,2049],\\\"backgroundColor\\\":\\\"#f28e2b\\\"},{\\\"label\\\":\\\"FY2026 Revised Forecast\\\",\\\"data\\\":[26500,4600],\\\"backgroundColor\\\":\\\"#ff9d9a\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}]","ir_related_company":7826,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"earnings_guidance","footnotes":""},"sector":[],"importance":[],"class_list":["post-23929","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n